Effect estimates were reported as odds ratios (ORs) with 95% confidence intervals (CIs), with statistical significance defined as <i>P</i> < .05.<h4>Results</h4>A total of 17142 patients with obesity and IBD were identified, including 12965 patients treated with GLP-1 RAs and 4177 patients who underwent BS. The gene discussed is GLP1R; the disease is inflammatory bowel disease.